Trupanion (NASDAQ:TRUP) Sets New 1-Year High – Here’s What Happened

Shares of Trupanion, Inc. (NASDAQ:TRUP) reached a new 52-week high on Friday . The stock traded as high as $49.67 and last traded at $49.37, with a volume of 238379 shares. The stock had previously closed at $47.06.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Evercore ISI raised Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler raised their price target on Trupanion from $38.00 to $45.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 2nd. Northland Securities lifted their price objective on Trupanion from $35.00 to $45.00 and gave the company a “market perform” rating in a report on Thursday, September 19th. Bank of America increased their price target on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research report on Friday, September 20th. Finally, Stifel Nicolaus upped their price target on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Four research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $41.83.

Trupanion Stock Up 4.2 %

The company has a market cap of $2.07 billion, a PE ratio of -108.95 and a beta of 1.73. The business has a 50-day simple moving average of $43.17 and a 200-day simple moving average of $33.39. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.04. The firm had revenue of $314.80 million for the quarter, compared to analysts’ expectations of $309.33 million. Trupanion had a negative net margin of 1.57% and a negative return on equity of 6.29%. The firm’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter last year, the company earned ($0.33) EPS. Equities research analysts anticipate that Trupanion, Inc. will post -0.34 EPS for the current year.

Insider Transactions at Trupanion

In related news, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at approximately $4,647,256.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CFO Fawwad Qureshi sold 624 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 8,764 shares of company stock valued at $405,238 over the last 90 days. Corporate insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Trupanion

A number of large investors have recently made changes to their positions in the stock. GAMMA Investing LLC boosted its stake in Trupanion by 70.4% during the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after buying an additional 596 shares during the last quarter. Headlands Technologies LLC purchased a new position in shares of Trupanion during the 2nd quarter worth $162,000. Oppenheimer Asset Management Inc. acquired a new position in shares of Trupanion during the 2nd quarter valued at about $235,000. Handelsbanken Fonder AB purchased a new stake in shares of Trupanion in the third quarter valued at about $248,000. Finally, Bayesian Capital Management LP acquired a new stake in Trupanion during the first quarter worth about $253,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.